News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025
News Conference News CRT 2024 Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis L.A. McKeown March 09, 2024
News Conference News CRT 2023 ‘Beeting’ In-stent Restenosis? Dietary Nitrate May Improve Outcomes Yael L. Maxwell February 27, 2023
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
News Daily News CRT 2021 COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold Michael O'Riordan March 17, 2021
News Conference News CRT 2021 BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients Caitlin E. Cox March 16, 2021
News Conference News CRT 2020 Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback Michael O'Riordan February 28, 2020
News Conference News CRT 2020 PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE Michael O'Riordan February 25, 2020
News Conference News CRT 2019 Blasting Off: Experience Grows for Intravascular Lithotripsy for Coronary Plaque Yael L. Maxwell March 15, 2019
News Conference News CRT 2019 Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy L.A. McKeown March 06, 2019
News Conference News CRT 2018 Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT Michael O'Riordan March 08, 2018
News Conference News CRT 2017 Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate Michael O'Riordan February 21, 2017